SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as traders discuss potential catalysts, including upcoming earnings and the company's cash position. Community members are debating the possibility of a short squeeze and the impact of Ryan Cohen's leadership, while also referencing technical levels like $20.50. Some investors express frustration with the stock's performance amid broader market gains.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the community discusses the potential impact of newly launching ETFs and the possibility of a supply shock. Discussions range from excitement about price movement to skepticism about decoupling from Bitcoin. Many are focused on long-term potential and accumulating more XRP.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending amid optimism in the AI sector, particularly regarding its potential role in custom chip solutions as highlighted by Google's Gemini 3. Community members are discussing the stock's potential to reach a $2 trillion market cap, while also debating if the current volatility signals a market top.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival (CCL) is trending amid a broad sell-off in cruise line stocks, sparked by disappointing revenue guidance from competitor Royal Caribbean. The community is debating whether this sell-off is an overreaction, given Carnival's strong earnings report, or a sign of broader economic concerns impacting the industry. Some traders are seizing the opportunity to buy the dip, while others express concern about the sector's vulnerability to external factors.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom Video Communications, Inc.

Zoom is trending as investors digest its recent earnings report and analysts weigh in with mixed reactions, including upgrades and target adjustments. Community discussions revolve around the company's growth prospects, particularly its AI initiatives, and its ability to compete with larger tech players. Some traders are expressing concerns about the stock's historical performance and overall market conditions.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune ($ALT) is trending amid community discussion around potential catalysts and the company's Pemvidutide drug. Community members are actively debating the drug's prospects, data integrity, and potential for acquisition, with some suggesting a buyout could be imminent. Broader discussions involve comparisons to competitors and speculation about potential partnerships within the biotech sector.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

FLNC is trending as the community discusses its potential for a short squeeze and long-term growth prospects in the energy storage sector. Bullish sentiment is fueled by discussion around analyst upgrades and potential revenue from contracts, especially as the need for battery solutions supporting AI infrastructure becomes more apparent. Some investors also speculate on potential benefits from BlackRock's involvement.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as the company has commercially launched Tonmya for fibromyalgia, generating mixed community sentiment regarding its potential impact and market adoption. While some view this as a turning point and anticipate significant revenue, others express concerns about dilution and the drug's efficacy compared to existing treatments. Discussions also involve institutional ownership, short squeeze potential, and the company's overall financial strategy.

Symbotic, Inc. is an automation technology company, which engages in a robotics and automation-based product movement technology platform. It focuses on developing, commercializing, and deploying innovative, end-to-end technology solutions for supply chain operations. It operates through the United States and Canada geographical segments. The company was founded by Richard B. Cohen on December 11, 2020 and is headquartered in Wilmington, MA.

Symbotic Inc - Ordinary Shares - Class A

Symbotic Inc 

SYM is trending as investors anticipate earnings, with a mix of bullish and cautious sentiment prevailing. The community is focused on whether the company can maintain its growth trajectory and manage high valuations. Discussions also center on the company's key partnership with Walmart and its potential impact on future performance in the automation sector.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

$IMG is trending as the community highlights its unique rewards system, which distributes $SOL to holders based on volume, whether the price increases or decreases. Community members are actively discussing the upcoming implementation of LP rewards and live audit technology, indicating excitement for the project's ongoing development. With a focus on passive income and transparent, on-chain rewards, $IMG aims to revolutionize DeFi and reward long-term holders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novo Nordisk A/S (NYSE:NVO) Lowered to "Hold" Rating by HSBC

HSBC reaffirmed a "hold" rating on shares of Novo Nordisk A/S in a research report on Monday...

Why Is Biogen Stock Trading Higher After Semaglutide Alzheimer's Data?

Biogen stock rises as Novo Nordisk's Alzheimer's trials disappoint, spotlighting Leqembi's role and a new immunology collaboration with Dayra Therapeutics.read more...

Holiday air travel, Novo Nordisk trial results, 'Wicked: For Good' debut and more in Morning Squawk

Here are five key things investors need to know to start the trading day...

Will NVO's U.S. Price Cuts Boost Access & Revive Semaglutide Demand?

Novo Nordisk cuts self-pay prices for Wegovy and Ozempic in the United States, aiming to expand access and counter falling demand.

Stock Market Today: Futures Tip Up to Start Week; Novo Nordisk Plummets After Ozempic Alzheimer's Miss

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here.Happy Monday. This is TheStreet's Stock...

Lilly Crosses $1 Trillion Market Cap: Here's What Is Driving the Rally

LLY hits a historic $1T valuation as booming GLP-1 sales from Mounjaro and Zepbound drive growth and expand momentum across its portfolio.

Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Novo Nordisk's Blockbuster Weight-Loss Drug Flops In Alzheimer's Trial

Novo Nordisk's stock falls as semaglutide Alzheimer's trials show no significant benefit in reducing disease progression.read more...

Novo Nordisk Plunges After Ozempic Pill Fails Alzheimer's Trials - Shares Suffer Worst Year Ever

Novo Nordisk Plunges After Ozempic Pill Fails Alzheimer's Trials - Shares Suffer Worst Year Ever Shares of Novo Nordisk in Copenhagen plunged the most in nearly four months after top-line results...

28,257 Shares in Novo Nordisk A/S $NVO Acquired by Longfellow Investment Management Co. LLC

Longfellow Investment Management Co. LLC purchased a new stake in Novo Nordisk A/S (NYSE:NVO - Free Report) during the second quarter, according to its most recent filing with the Securities...

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

$LLY

$NVO

$VKTX

$HIMS

Which weight-loss stock are you most bullish on for the next 5 years?

Current Price	$44.97
Prev Close	$47.63
Open	$43.43
Dividend Yield	1.37%
50-Day Moving Average	$53.91
Beta	0.70
Avg. Volume	12.12M
PE Ratio	13.85

52-Week High	$112.52
52-Week Low	$45.05
Market Capitalization	$160.45B
EPS (Annual)	$3.29
Price to Book	7.91
Revenue Per Employee	$551,951.47
Enterprise Value/EBITDA	N/A

NVO
Novo Nordisk A/S

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NVO News

NVONovo Nordisk A/S